Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffrey A Engelman
Transformation From NSCLC to SCLC: When Did It Happen? – Authors' Reply
The Lancet Oncology
Oncology
Targeting the PI3K Signaling Pathway in Cancer
Current Opinion in Genetics and Development
Genetics
Developmental Biology
Effective Use of PI3K and MEK Inhibitors to Treat Mutant Kras G12D and PIK3CA H1047R Murine Lung Cancers
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
New Developments in the Diagnosis and Treatment of Thyroid Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
No Cost or Safety Advantage to Robot-Assisted Radical Prostatectomy Compared With Open-Procedure Surgery for Patients With Prostate Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Challenges in Ductal Carcinoma in Situ Risk Communication and Decision-Making
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Risk Factors, Pathophysiology, and Treatment of Hot Flashes in Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Angiogenesis Inhibitors: Current Strategies and Future Prospects
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Population-Based Programs for Increasing Colorectal Cancer Screening in the United States
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Treatment and Survivorship Statistics, 2019
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Germline Mutations in Pancreatic Cancer Become Better Defined
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening
CA - A Cancer Journal for Clinicians
Oncology
Hematology